Cite

HARVARD Citation

    Price, D. et al. (2018). The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease. Scientific reports. 8 (1), pp. 1-12. [Online]. 
  
Back to record